Genprex Inc. (NASDAQ: GNPX) Hires Top Pharmaceutical Branding Agency to Oversee Drug Naming Process for Lead Drug Candidate

May 29, 2019 10:18:07
  • Genprex, a clinical stage gene therapy company, will be utilizing the services of a leading pharmaceutical branding agency to oversee the naming process of its lead drug candidate, Oncoprex
  • Addison Whitney has over 28 years of experience in the market, guiding pharmaceutical companies such as Merck, Celgene and Roche through the regulatory steps involved in the name approval process
  • Oncoprex is an innovative immunogene therapy targeting non-small cell lung cancer

Genprex Inc. (NASDAQ: GNPX), a clinical stage gene therapy company, recently reported that it has retained the services of leading pharmaceutical branding agency Addison Whitney to assist with the naming of the company’s leading drug candidate (

The move will enable Genprex to pursue the commercialization of Oncoprex immunogene therapy, which is currently in development and undergoing a clinical trial for the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office